Brief: Xortx Announces Closing Of Acquisition Of Vectus Kidney Anti-Fibrotic Asset
13/04/2026 22:09
April 13 (Reuters) - XORTX Therapeutics Inc XRTX.V: XORTX ANNOUNCES CLOSING OF ACQUISITION OF VECTUS KIDNEY ANTI-FIBROTIC ASSET Source text: ID:nGNX8JK2Ml Further company coverage: XRTX.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering